Cannabis Weekly Round-Up: Peru on Path for Legal Medical Cannabis
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
Your trusted source for investing success
Your trusted source for investing success
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
By Shelly Kumar
Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV:FIRE) is pleased to announce its wholly owned subsidiary, 7ACRES, has completed a sale of dried cannabis to Emerald Health Botanicals Inc. (“Emerald”), a wholly owned subsidiary of Emerald Health Therapeutics, Inc. (TSXV:EMH). Emerald is a Canadian Licensed Producer with a focus on
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
By Jocelyn Aspa
The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.
By Shelly Kumar
Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE)is pleased to announce its wholly owned subsidiary, 7ACRES, has completed its first sale of dried cannabis to Aurora Cannabis Inc. (“Aurora”), one of Canada’s leading Licensed Producers. Aurora will sell cannabis procured from 7ACRES to its medical cannabis patients with a
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
This past trading in the cannabis marketplace saw another major dip to the Marijuana Life Sciences Index, the first medical marijuana study funded by a US medical government research group.
From Canadian LPs banding together asking for tougher promotional regulations to the acquisition of ABcann by Cannabis Wheaton and a variety of market news INN provides a roundup of the week in cannabis.
The introduction of advertising regulations with support from Advertising Standards Canada (ASC) to be adopted in the branding and promotion of cannabis.
From Uruguay’s full legalization to the debate between regional leaders in Canada questioning the recreational deadline, and a variety of market news INN provides a roundup of the week in cannabis
INN had the chance to catch up with John Fowler, president of Supreme Pharmaceuticals to discuss what the company’s been up to recently.
A quick look of some of the major events in the cannabis industry this week.
Supreme Pharmaceuticals announced its subsidiary 7 Acres received an update from Health Canada regarding a cultivation license.
Friday Night Inc, formerly QuikFlo Health Inc. (the “Company”) (CSE:TGIF) (FRANKFURT:1QF) announces that in conjunction with the closing of its previously announced acquisition of interests in two cannabis based businesses located in Las Vegas, Nevada, it has changed its name to Friday Night Inc. and consolidated its shares on a
Supreme Pharmaceuticals announced it will be moving its listing to the TSX Venture Exchange.
The marijuana sector in Canada is heating up, and publicly traded cannabis companies are performing well since entering the scene. Here’s a brief overview of some of the top gainers.
By Jocelyn Aspa
Supreme Pharmaceuticals (CSE:SL) has announced it has received conditional approval from the TSX Venture Exchange to list its shares on the TSXV.
As quoted in the press release:
John Fowler, President and CEO, stated: “Graduating from the CSE to the TSX.V is an important milestone for Supreme. We enjoyed tremendous success throughout
By Jocelyn Aspa
Supreme Pharmaceuticals (CSE:SL) has announced that its wholly-owned subsidiary, 7 ACRES, has received license renewal to cultivate cannabis.
As quoted in the press release:
Supreme also understands that Health Canada is in the final phase of its review of 7 ACRES’ application (the “Application”) for the authorization to sell bulk cannabis. The
By Jocelyn Aspa
Recreational marijuana is legal in Nevada. David Stadnyk, president of Friday Night, weighs in on what makes the state an exciting space to operate.
By Jocelyn Aspa
The Canadian cannabis stocks industry is on the rise, with increasing demand coming from recreational and medicinal users.
